Patent · US Active

Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use as ATR kinase inhibitors

US12264155B2 · kind B2 · utility

0Cited by
23References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 30, 2021
Grant dateApr 1, 2025
Priority date
Expiry dateNov 23, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/05
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Disclosed are compounds and pharmaceutically acceptable salts thereof that may be used in the treatment of subjects in need thereof. The compounds disclosed herein may be inhibitors of Ataxia-telangiectasia and RAD-3-related protein kinase (ATR). Also disclosed are pharmaceutical compositions containing the compounds or pharmaceutically acceptable salts thereof and methods of their preparation and use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.